BENGALURU: Cognizant has made its second-biggest acquisition after it purchased US engineering R&D companies agency Belcan for $1.3 billion, which contains $1.1 billion in money and 1.4 million Cognizant shares valued at $97 million based mostly on its closing share value on Friday. Ten years in the past, Cognizant acquired healthcare options agency TriZetto for $2.7 billion.
The Belcan acquisition is predicted to bolster Cognizant’s ER&D capabilities, much like French IT agency Capgemini increasing its ER&D playbook by buying Altran for $4 billion in 2020.Sources instructed TOI that Cognizant’s swift M&A comes at a time when Infosys has narrowed its lead over Cognizant. But with this acquisition, the hole between the 2 corporations widens. Cognizant is bulking up revenues with the Belcan deal that will contribute $800 million on an annualised foundation and it’ll add over 6,500 engineers and technical consultants.
The Belcan acquisition is predicted to bolster Cognizant’s ER&D capabilities, much like French IT agency Capgemini increasing its ER&D playbook by buying Altran for $4 billion in 2020.Sources instructed TOI that Cognizant’s swift M&A comes at a time when Infosys has narrowed its lead over Cognizant. But with this acquisition, the hole between the 2 corporations widens. Cognizant is bulking up revenues with the Belcan deal that will contribute $800 million on an annualised foundation and it’ll add over 6,500 engineers and technical consultants.
